BidaskClub lowered shares of Utah Medical Products (NASDAQ:UTMD) from a buy rating to a hold rating in a research note released on Saturday morning, BidAskClub reports.

Shares of NASDAQ UTMD opened at $96.59 on Friday. The firm has a market cap of $360.36 million, a PE ratio of 26.40 and a beta of 0.81. The company’s fifty day simple moving average is $93.62 and its 200 day simple moving average is $87.22. Utah Medical Products has a 12-month low of $73.98 and a 12-month high of $102.70.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter. The business had revenue of $11.85 million for the quarter. Utah Medical Products had a return on equity of 15.13% and a net margin of 39.37%.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 3rd. Stockholders of record on Friday, September 13th will be issued a dividend of $0.275 per share. The ex-dividend date is Thursday, September 12th. This represents a $1.10 annualized dividend and a dividend yield of 1.14%.

Several large investors have recently modified their holdings of the company. Rehmann Capital Advisory Group acquired a new stake in Utah Medical Products in the 2nd quarter valued at $29,000. Bank of Montreal Can grew its holdings in shares of Utah Medical Products by 312.8% during the second quarter. Bank of Montreal Can now owns 388 shares of the medical instruments supplier’s stock valued at $37,000 after buying an additional 294 shares during the last quarter. BNP Paribas Arbitrage SA grew its holdings in shares of Utah Medical Products by 428.7% during the first quarter. BNP Paribas Arbitrage SA now owns 719 shares of the medical instruments supplier’s stock valued at $63,000 after buying an additional 583 shares during the last quarter. Krane Funds Advisors LLC acquired a new position in shares of Utah Medical Products during the second quarter valued at about $70,000. Finally, Aperio Group LLC bought a new stake in shares of Utah Medical Products during the second quarter worth about $76,000. 75.09% of the stock is currently owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Featured Story: Google Finance

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.